Profile
| Metric | Value |
|---|---|
| Full Name | Zenas BioPharma, Inc. |
| Ticker | NASDAQ: ZBIO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | zenasbio.com |
| Employees | 130 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $18.37 | |
| Price, 1D Change | -12.02% | |
| $986M | ||
| - | ||
| - | ||
| 1.42 | ||
| $5M | ||
| Revenue, 1Y Change | -90.00% | |
| -$3.76 | ||
| EPS, 1Y Change | -287.69% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:2 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.76 | ||
| EPS Estimate | -$4.39 | |
| EPS Est. Change | -16.87% | |
| $5.00M | ||
| Revenue Estimate | $26.43M | |
| Revenue Est. Change | +428.57% | |
| Current Price | $18.37 | |
| Price Target | - | $44.50 |
| Price Tgt. Change | - | +142.24% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$7.04 | -$3.76 | +46.65% | |
| -$4.39 | N/A | -16.87% | |
| -$3.94 | N/A | -4.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $5.00M | - | |
| $26.43M | N/A | +428.57% | |
| $17.72M | N/A | +254.33% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $18.37 | |
| $20.37 | ||
| SMA 200 vs Price | +10.89% | |
| $30.89 | ||
| SMA 50 vs Price | +68.13% | |
| 1.42 | ||
| $2.65 | ||
| 36.88 | ||
| 91.31% | ||
| 122.15% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $5.00M | ||
| -$3.76 | ||
| $4.86M | ||
| 97.26% | ||
| -$163.89M | ||
| -3,277.76% | ||
| -$156.99M | ||
| -3,139.76% | ||
| -$163.75M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.21 | ||
| 6.21 | ||
| - | ||
| - | ||
| 8.34 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 65.74 | ||
| 5.02 | ||
| -3.56 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $312.46M | ||
| $319.74M | ||
| $369.97M | ||
| $355.92M | ||
| $57.51M | ||
| $57.29M | ||
| $1.00M | ||
| $785.00K | ||
| $17.14M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $168.89M | ||
| $168.89M | ||
| $137.00K | ||
| $29.75M | ||
| $137.00K | ||
| $0.00 | ||
| $429.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$119.67M | ||
| -$30.55M | ||
| $412.96M | ||
| $131.00K | ||
| -$119.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Morgan Stanley | → | |
| Wedbush | → | |
| Evercore ISI Group | ||
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with ZBIO
FAQ
What is the ticker symbol for Zenas BioPharma, Inc.?
The ticker symbol for Zenas BioPharma, Inc. is NASDAQ:ZBIO
Does Zenas BioPharma, Inc. pay dividends?
No, Zenas BioPharma, Inc. does not pay dividends
What sector is Zenas BioPharma, Inc. in?
Zenas BioPharma, Inc. is in the Healthcare sector
What industry is Zenas BioPharma, Inc. in?
Zenas BioPharma, Inc. is in the Biotechnology industry
What country is Zenas BioPharma, Inc. based in?
Zenas BioPharma, Inc. is headquartered in United States
When did Zenas BioPharma, Inc. go public?
Zenas BioPharma, Inc. initial public offering (IPO) was on September 13, 2024
Is Zenas BioPharma, Inc. in the S&P 500?
No, Zenas BioPharma, Inc. is not included in the S&P 500 index
Is Zenas BioPharma, Inc. in the NASDAQ 100?
No, Zenas BioPharma, Inc. is not included in the NASDAQ 100 index
Is Zenas BioPharma, Inc. in the Dow Jones?
No, Zenas BioPharma, Inc. is not included in the Dow Jones index
When was Zenas BioPharma, Inc. last earnings report?
Zenas BioPharma, Inc.'s most recent earnings report was on November 12, 2025
When does Zenas BioPharma, Inc. report earnings?
The next expected earnings date for Zenas BioPharma, Inc. is March 17, 2026
Data Sources & References
- ZBIO Official Website zenasbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1953926/000110465925109753/0001104659-25-109753-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1953926/000155837025002631/0001558370-25-002631-index.htm
- ZBIO Profile on Yahoo Finance finance.yahoo.com/quote/ZBIO
- ZBIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/zbio